{
    "Case ID": "076097",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement under the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Legal_Issue": [
        "Whether Apotex's proposed pantoprazole product infringes Altana's patents ('694 and '748)"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations, s. 6(1)"
    ],
    "Procedural_Stage": [
        "Application hearing under the NOC Regulations"
    ],
    "Evidence_Assessment": [
        "Expert evidence presented by both parties on patent construction, eligibility, and infringement"
    ],
    "Decision_Outcome": [
        "Application dismissed"
    ],
    "Burden_of_Proof": [
        "On Altana to prove that Apotex's allegations of non-infringement were unjustified"
    ],
    "Credibility_Factor": [
        "Court assessed credibility of expert testimony and product monograph interpretation"
    ],
    "Legal_Rule": [
        "Under s. 6(1), the Court must determine if allegations of non-infringement are justified"
    ],
    "Standard_of_Review": [
        "Balance of probabilities"
    ],
    "Procedural_Issue": [
        "Five-day hearing conducted with full evidentiary submissions"
    ],
    "Grounds_for_Claim": [
        "Alleged infringement of patents related to specific formulations or uses of pantoprazole"
    ],
    "Outcome_on_Merits": [
        "Apotex's allegations of non-infringement found justified"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Not applicable – this was a first-instance application"
    ],
    "Review_Standard": [
        "De novo review of questions of law and fact under NOC proceedings"
    ],
    "Procedural_Fairness_Assessment": [
        "Both parties had full opportunity to present evidence and argument"
    ],
    "Key_Evidence_Considered": [
        "Product monograph of Apotex’s proposed drug, expert opinions on patent claims"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "Altana sought to prevent Apotex from obtaining a Notice of Compliance"
    ],
    "Court_Result": [
        "Dismissal of Altana's application"
    ],
    "Legal_Rule_Source": [
        "Statutory: Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Apotex alleged non-infringement based on formulation and intended use differences"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert testimony"
    ],
    "Remedy_Requested": [
        "Interim injunction to prevent market entry of generic pantoprazole"
    ],
    "Outcome": [
        "Remedy denied"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Prevention of marketing of generic pantoprazole until patent expiry"
    ],
    "Resolution_Mechanism": [
        "Judicial determination following adversarial hearing"
    ],
    "Legal_Provision": [
        "Section 6(1) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Federal Court"
    ],
    "Claimant_Status": [
        "Patent holder (Altana)"
    ],
    "Legal_Provision_Cited": [
        "s. 6(1) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Non-infringement due to lack of inducement and different product formulation"
    ],
    "Applicable_Process": [
        "NOC proceeding under the PM(NOC) Regulations"
    ],
    "Outcome_of_Review": [
        "No infringement established; application dismissed"
    ],
    "Pending_Relief_or_Application": [
        "Application for prohibition of market entry"
    ],
    "Jurisdiction": [
        "Federal jurisdiction – intellectual property/patent law"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}